NCT06964477Not yet recruiting
A Trial of Extended Reality Activities to Enhance Leisure Participation Among Inpatients With Persistent Mental Health Conditions
A Randomized Controlled Trial of an Extended Reality-Based Occupational Therapy Intervention to Improve Leisure Participation in Inpatients With Persistent Mental Health Conditions
Source: ClinicalTrials.gov · Last updated 9 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the effects of an extended reality (XR)-enhanced occupational therapy leisure intervention on motivation, emotional engagement, and therapeutic participation among inpatients with chronic psychiatric conditions. The main questions it aims to answer are: Can the XR intervention improve leisure motivation, leisure-related attitudes, and emotional coping strategies in long-term hospitalized individuals with mental illness? Does the XR intervention promote improvements in psychological health, volition, and occupational performance? Researchers will compare an XR-based leisure therapy group to a usual care group engaged in standard hospital leisure activities such as art, music, or reading. Participants will take part in weekly 40-minute sessions for 6 weeks. The XR group will use a custom-designed mobile VR program featuring immersive 360° leisure scenarios aligned with participants' interests and functional goals. Data collection includes standardized assessments (e.g., Interest Checklist, Volitional Questionnaire, COPM, PANSS) and semi-structured interviews to explore changes in motivation, coping, and perceived benefits.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- First submitted
- 1 May 2025
- Start date
- 1 Jul 2025
- Primary completion date
- 15 Sept 2025
- Lead sponsor
- Chia-Hui Hung
- Diseases
- Schizophrenia
- NCT number
- NCT06964477
What you commit to
- Study type: Interventional
- Planned participants: 25
- From 1 Jul 2025 to the primary completion date, 15 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of epilepsy, severe motion sickness, or other seizure-related conditions
- Physical conditions that limit participation in leisure activities
- Current diagnosis of substance abuse or major organic brain disorder
Other
- Significant visual or auditory impairments that may interfere with XR experience
- Inability to distinguish between reality and virtual environments
Who the study is looking for
- Adults aged 20 to 65 years
- Diagnosed with chronic schizophrenia or schizoaffective disorder (ICD-10 F20.x or F25.x)
- Hospitalized continuously for at least 6 months
- Clinically stable with no acute psychiatric symptoms
- Able to walk independently and communicate verbally
- Mini-Mental State Examination (MMSE) score ≥ 24
Age in the registry: 20 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jing-Ho Hospital Coordinator of this site? Confirm its status | Taichung | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.